Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study
about
The promise of neuroprotective agents in Parkinson's diseaseNeuroinflammation in Parkinson's disease and its potential as therapeutic targetAdaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesInflammation as a causative factor in the aetiology of Parkinson's diseaseDeath in the substantia nigra: a motor tragedy.Innate and adaptive immunity for the pathobiology of Parkinson's diseaseAspirin down Regulates Hepcidin by Inhibiting NF-κB and IL6/JAK2/STAT3 Pathways in BV-2 Microglial Cells Treated with Lipopolysaccharide.Vulnerability of mesostriatal dopaminergic neurons in Parkinson's diseaseHighly reactive oxygen species: detection, formation, and possible functions.Protective Mechanisms of Flavonoids in Parkinson's Disease.Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation.Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View.Monoamine oxidase-induced hydroxyl radical production and cardiomyocyte injury during myocardial ischemia-reperfusion in rats.Cyclooxygenase-independent neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity.
P2860
Q21129436-874F961B-BAC2-4E33-97D3-3F4B62AAD0BAQ26783305-C24EECE1-8F94-470F-9511-790038F510B4Q34071942-96D37E6C-7FD5-45F6-B757-CB9844613EACQ36052641-E783CB82-6B37-4E29-922F-14ECA2E4A893Q36847262-230E907D-3C7D-4640-ACD4-2ABA2457687DQ37401280-309D3DDE-BFC1-48B4-ADD3-AA1E38F0494FQ37534483-CFD089C0-779D-4F79-8BDB-AC7EF5DC36EBQ37809751-76DD3D46-64CE-408C-9383-DA833FACE4C2Q37870856-A455566C-B08F-469F-B413-1AD34DDBAA08Q38635687-0575886E-6ECA-44B1-AD19-E9B60A71C29CQ38974344-4F10E925-1DD7-407C-AF25-F87D325F0DC3Q38994712-83249B9D-17F1-4ADC-B418-426417171BF4Q46583405-678B400E-38C6-43C8-B1CB-D15A3FA18E0BQ48481582-C4CF0D4A-19AD-4D0C-9DF5-09F1338F91AB
P2860
Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Aspirin protects striatal dopa ...... an in vivo microdialysis study
@ast
Aspirin protects striatal dopa ...... an in vivo microdialysis study
@en
Aspirin protects striatal dopa ...... an in vivo microdialysis study
@nl
type
label
Aspirin protects striatal dopa ...... an in vivo microdialysis study
@ast
Aspirin protects striatal dopa ...... an in vivo microdialysis study
@en
Aspirin protects striatal dopa ...... an in vivo microdialysis study
@nl
prefLabel
Aspirin protects striatal dopa ...... an in vivo microdialysis study
@ast
Aspirin protects striatal dopa ...... an in vivo microdialysis study
@en
Aspirin protects striatal dopa ...... an in vivo microdialysis study
@nl
P2093
P921
P1433
P1476
Aspirin protects striatal dopa ...... an in vivo microdialysis study
@en
P2093
Andreina Poggi
Angelo Di Santo
Arcangelo Benigno
Ennio Esposito
Massimo Pierucci
Vincenzo Di Matteo
P304
P356
10.1016/J.BRAINRES.2006.04.013
P407
P577
2006-06-20T00:00:00Z